Leveraging Viruses for the Treatment of Viral Diseases and Cancer

216 Seiten, Taschenbuch

Kurzbeschreibung des Verlags

Leveraging Viruses for the Treatment of Viral Diseases and Cancer: Improving Host Fitness by Combinations of Virus and Host Genes gives a comprehensive overview on the impact of using naturally or intentionally attenuated viruses - which are apathogenic to people - to control viral diseases and cancer. It examines the potential of exploiting, developing, and using apathogenic viruses as therapeutic tools. Sections cover the COVID-19 pandemic and the need for a post-Infection Plan B to combat SARS-CoV-2 infections as gaps in testing and vaccination create the perfect conditions for a new variant of concern to emerge.More generally, the book also provides specific examples of the use of apathogenic viruses to treat other infectious diseases. It discusses the process of manufacturing viral therapies and how infectious disease treatments can be repurposed to improve other therapies like for cancer. With contribution from an international group of contributors, Leveraging Viruses for the Treatment of Viral Diseases and Cancer is useful references for those engages in study and development of infectious diseases and ways to combat them.

• Reihe: Academic Press
• ISBN: 9780443291647
• Sprache: Englisch
• Erscheinungsdatum: 07.11.2025
• Größe: 229 x 152 mm
• Verlag: Elsevier Inc
• Herausgegeben von: Tibo Bakacs